Cargando…

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial

Aim: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) forms a significant component of oxidised LDL. The effects of exercise on levels of MDA-LDL and anti-MDA-LDL antibodies are not well-understood. Furthermore, it is not known whether these can be modified in patients with coronary artery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartley, Adam, Shun-Shin, Matthew, Caga-Anan, Mikhail, Rajkumar, Christopher, Nowbar, Alexandra N., Foley, Michael, Francis, Darrel P., Haskard, Dorian O., Khamis, Ramzi Y., Al-Lamee, Rasha K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542769/ https://www.ncbi.nlm.nih.gov/pubmed/34708098 http://dx.doi.org/10.3389/fcvm.2021.757030

Ejemplares similares

Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial( )
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022)

Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022)

Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial
por: McCreanor, Victoria, et al.
Publicado: (2021)

Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding
por: Nowbar, Alexandra N, et al.
Publicado: (2021)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
por: Khan, Tina Z., et al.
Publicado: (2021)

A Novel Immunoassay for Malondialdehyde-Conjugated Low-Density Lipoprotein Measures Dynamic Changes in the Blood of Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Pandey, Samata S., et al.
Publicado: (2021)

Anti-Oxidized LDL Antibodies and Coronary Artery Disease: A Systematic Review
por: van den Berg, Victor J., et al.
Publicado: (2019)

Achieving Optimal Medical Therapy: Insights From the ORBITA Trial
por: Foley, Michael, et al.
Publicado: (2021)

Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography–Stratified Analysis of ORBITA
por: Al-Lamee, Rasha K., et al.
Publicado: (2019)

Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
por: Hartley, Adam, et al.
Publicado: (2022)

Achieving optimal adherence to medical therapy by telehealth: Findings from the ORBITA medication adherence sub‐study
por: Thompson, David, et al.
Publicado: (2021)

High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial()
por: Khamis, Ramzi Y., et al.
Publicado: (2016)

Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
por: Chacko, Liza, et al.
Publicado: (2020)

Markers of Apoptosis Predict Cardiovascular Outcomes and Point to ‘Response to Injury’ as a Common Pathway Leading to Diabetes and Cardiovascular Events
por: Hartley, Adam, et al.
Publicado: (2018)

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
por: van den Berg, Victor J., et al.
Publicado: (2018)

Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease
por: Rajkumar, Christopher A., et al.
Publicado: (2021)

Mortality From Ischemic Heart Disease: Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration
por: Nowbar, Alexandra N., et al.
Publicado: (2019)

Órbita
por: Moreno Fraginals, Manuel
Publicado: (2009)

Orbita
por: Escardo, Rolando Tomas, 1925-1960
Publicado: (1981)

Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis
por: Kelshiker, Mihir A, et al.
Publicado: (2021)

ORBITA Trial: Redefining the Role of Intervention in the Treatment of Stable Coronary Disease?
por: Albuquerque, Luciano Cabral, et al.
Publicado: (2018)

The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol
por: Khan, Sarosh, et al.
Publicado: (2023)

Voice Biomarkers: The Most Modern and Least Invasive Tool for Coronary Assessment?
por: Hartley, Adam, et al.
Publicado: (2022)

Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes
por: Fujihara, Kazuya, et al.
Publicado: (2015)

Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials
por: Rashid, Muhammad, et al.
Publicado: (2022)

Developing a Strategy for Interventional Molecular Imaging of Oxidized Low-Density Lipoprotein in Atherosclerosis
por: Pandey, Samata S., et al.
Publicado: (2017)

Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation
por: Yang, Tzu-Ching, et al.
Publicado: (2014)

Correction to: Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials
Publicado: (2022)

Órbita : los astronautas de la NASA fotografían la tierra
por: Apt, Jay
Publicado: (1999)

Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients
por: Rahsepar, Amir Ali, et al.
Publicado: (2015)

Orbita de Fernando Ortíz
por: Ortíz, Fernando, 1881-1969
Publicado: (1973)

Orbita de Juan Marinello
por: Marinello, Juan, 1898-1977
Publicado: (1968)

Tomografía computada de órbitas
por: Silvestre Xaca, Roberto
Publicado: (2013)

Órbita de Virgilio Piñera /
por: Piñera, Virgilio, 1912-1979
Publicado: (2011)

Revoluciones de las órbitas celestes /
por: Copérnico, Nicolás, 1473-1543
Publicado: (1969)

Orbita de José Z. Tallet
por: Tallet, José Zacarías
Publicado: (1969)

Órbita de Lino Novás Calvo /
por: Novás Calvo, Lino, 1905-1983
Publicado: (2008)

The argument of the ORBITA study: angioplasty is useless
por: Bolognese, Leonardo
Publicado: (2020)

Fractional flow reserve in acute coronary syndromes: A review
por: Shah, Nikunj R., et al.
Publicado: (2014)

Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessment
por: Seligman, Henry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mknp860o3tj42jbi0imdmvmbdn